The immunostimulating role of lichen polysaccharides: A review

Phytotherapy Research

Volumn 29, Issue 3, 2015, Pages 317-322

  Shrestha, Gajendra ^a   St Clair, Larry L ^a   O'Neill, Kim L ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

dendritic cells; immunostimulation; lichens; macrophages; natural products; polysaccharides

Indexed keywords

ALPHA DEXTROGLUCAN; ALPHA INTERFERON; BETA GLUCAN; BETA INTERFERON; GALACTOFURANAN RICH HETEROPOLYSACCHARIDE; GALACTOFURANOMANNAN; GALACTOGLUCOMANNAN; GALACTOMANNAN; HETEROGLYCAN; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; ISOLICHENAN; KI M 7; LICHEN POLYSACCHARIDE; LICHENAN; NITROUS OXIDE; PC 1; PC 2; PC 3; PC 4; POLYSACCHARIDE; THS 4; THS 5; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VANADYL DERIVATIVE; IMMUNOLOGICAL ADJUVANT; NITRIC OXIDE;

ALGA; CANCER GROWTH; CARCINOGENESIS; CYANOBACTERIUM; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG DESIGN; FUNGUS; HUMAN; IMMUNE SYSTEM; IMMUNOSTIMULATION; LICHEN (ORGANISM); MACROPHAGE; NONHUMAN; REVIEW; SYMBIOSIS; ANIMAL; CHEMISTRY; DRUG EFFECTS; IMMUNOLOGY;

ALGAE; FUNGI;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; DENDRITIC CELLS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-1BETA; LICHENS; MACROPHAGES; NITRIC OXIDE; POLYSACCHARIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84924336719     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5251     Document Type: Review

References (69)

1. Baran J, Allendorf DJ, Hong F, Ross GD,. 2007. Oral β-glucan adjuvant therapy converts nonprotective Th2 response to protective Th1 cell-mediated immune response in mammary tumor-bearing mice. Folia Histochem Cytobiol 45: 107-114.
2. Borchers AT, Keen CL, Gershwin ME,. 2004. Mushrooms, tumors, and immunity: an update. Exp Biol Med (Maywood) 229: 393-406.
3. Burnet FM,. 1970. The concept of immunological surveillance. Prog Exp Tumor Res 13: 1-27.
4. Carbonero ER, Cordeiro L, Mellinger CG, et al. 2005. Galactomannans with novel structures from the lichen Roccella decipiens Darb. Carbohydr Res 340: 1699-1705.
5. Carbonero, ER, Ruthes, AC, Freitas, CS, et al,. 2012. Chemical and biological properties of a highly branched β-glucan from edible mushroom Pleurotus sajor-caju. Carbohydr Polym 90: 814-819.
6. Chan GC, Chan WK, Sze DM,. 2009. The effects of beta-glucan on human immune and cancer cells. J Hematol Oncol 2: 25.
7. Classen A, Lloberas J, Celada A,. 2009. Macrophage activation: classical versus alternative. Methods Mol Biol 531: 29-43.
8. Cordeiro, L, Carbonero, ER, Sassaki, GL, et al,. 2005. A fungus-type β-galactofuranan in the cultivated Trebouxia photobiont of the lichen Ramalina gracilis. FEMS Microbiol Lett 244: 193-198.
9. Cordeiro L, de Oliveira SM, Buchi DF, Iacomini M,. 2008. Galactofuranose-rich heteropolysaccharide from Trebouxia sp., photobiont of the lichen Ramalina gracilis and its effect on macrophage activation. Int J Biol Macromol 42: 436-440.
10. Diasio RB, LoBuglio AF,. 1996. Immunomodulators: immunosuppressive agents and immunostimulants. In, Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, (eds) The Pharmacological Basis of Therapeutics, 9th edn. McGraw-Hill Companies Inc., New York, 1291-1307.
11. El Enshasy HA, Hatti-Kaul R,. 2013. Mushroom immunomodulators: unique molecules with unlimited applications. Trends Biotechnol 31: 668-677.
12. Fahselt D,. 1994. Carbon metabolism in lichens. Symbiosis 17: 127-182.
13. Fangkrathok N, Junlatat J, Umehara K, Noguchi H, Sripanidkulchai B,. 2013. Cytotoxic and immunomodulatory effects of polyhydroxyoctane isolated from Lentinus polychrous mycelia. J Nat Med 68: 302-309.
14. Freysdottir J, Omarsdottir S, Ingolfsdottir K, Vikingsson A, Olafsdottir ES,. 2008. In vitro and in vivo immunomodulating effects of traditionally prepared extract and purified compounds from Cetraria islandica. Int Immunopharmacol 8: 423-430.
15. Fukuoka, F, Nakanishi M, Shibata S, Nishikawa Y, Takeda T, Tanaka M,. 1968. Polysaccharides in lichens and fungi. II. Antitumor activities on sarcoma-180 of the polysaccharide preparations from Gyrophora esculenta Miyoshi, Cetraria islandica (L.). Ach. var. orientalis Asahina, and some other lichens. GANN 59: 421-432.
16. Galluzzi L, Senovilla L, Zitvogel L, Kroemer G,. 2012. The secret ally: immunostimulation by anticancer drugs. Nat Rev Drug Discov 11: 215-233.
17. Giavasis I,. 2014. Bioactive fungal polysaccharides as potential functional ingredients in food and nutraceuticals. Curr Opin Biotechnol 26: 162-173.
18. Gorin PAJ, Iacomini M,. 1984. Polysaccharides of the lichens Cetraria islandica and Ramalina usnea. Carbohydr Res 128: 119-132.
19. Gorin PAJ, Baron M, Silva MLC, Teixeira AZA, Iacomini M, 1993. Lichen carbohydrates. Ciência e Cultura 45: 27-36.
20. Hirabayashi K, Iwata S, Ito M, et al,. 1989. Inhibitory effect of a lichen polysaccharide sulfate, GE-3-S, on the replication of human immunodeficiency virus (HIV) in vitro. Chem Pharmaceut Bull 37: 2410.
21. Hranisavljevic-Jakovljevic M, Miljkovic-Stojanovic J, Dimitrijevic R, Micovic VM,. 1980. An alkali-soluble polysaccharide from the oak lichen Cetraria islandica (L.) Ach. Carbohydr Res 80: 291-295.
22. Hsu HY, Hua KF, Lin CC, Lin CH, Hsu J, Wong CH,. 2004. Extract of Reishi polysaccharides induces cytokine expression via TLR4-modulated protein kinase signaling pathways. J Immunol 173: 5989-5999.
23. Ingolfsdottir K, Jurcic K, Fischer B, Wagner H,. 1994. Immunologically active polysaccharide from Cetraria islandica. Planta Med 60: 527-531.
24. Ingolfsdottir K, Jurcic K, Wagner H,. 1998. Immunomodulating polysaccharides from aqueous extracts of Cetraria islandica (Iceland moss). Phytomedicine 5: 333-339.
25. Janeway Jr CA, Medzhitov R,. 2002. Innate immune recognition. Sci Signal 20: 197.
26. Jensen J, Petersen B, Veselinovic T, Olafsdottir E, Duus J, Omarsdottir S,. 2010. Structural characterisation of a new O-methylated heteroglycan, colleman, from the cyanolichen Collema flaccidum. Carbohydr Polym 80: 799-807.
27. Karunaratne DN, Jayalal R, Karunaratne V,. 2012. Lichen polysaccharides. The complex world of polysaccharides. ISBN, 978-953.
28. Kataoka K, Muta T, Yamazaki S, Takeshige K,. 2002. Activation of macrophages by linear (1 → 3)-β-D-glucans implications for the recognition of fungi by innate immunity. J Biol Chem 277: 36,825-36,831.
29. Kayser O, Masihi KN, Kiderlen AF,. 2003. Natural products and synthetic compounds as immunomodulators. Expert Rev Anti Infect Ther 1: 319-335.
30. Kim HS, Kim JY, Lee HK, et al,. 2010. Dendritic cell activation by glucan isolated from Umbilicaria esculenta. Immune Netw 10: 188-197.
31. Klimp A, De Vries E, Scherphof G, Daemen T,. 2002. A potential role of macrophage activation in the treatment of cancer. Crit Rev Oncol Hematol 44: 143-161.
32. Kumar S, Gupta P, Sharma S, Kumar D,. 2011. A review on immunostimulatory plants. Zhong Xi Yi Jie He Xue Bao 9: 117-128.
33. Lambert G, Estevez-Salmeron L, Oh S, et al,. 2011. An analogy between the evolution of drug resistance in bacterial communities and malignant tissues. Nat Rev Cancer 11: 375-382.
34. Leao AM, Buchi DF, Iacomini M, Gorin PA, Oliveira MB,. 1997. Cytotoxic effect against HeLA cells of polysaccharides from the lichen Ramalina celastri. J Submicrosc Cytol Pathol 29: 503-509.
35. Li B, Cai Y, Qi C, et al,. 2010. Orally administered particulate β-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancer. Clin Cancer Res 16: 5153-5164.
36. Lin J-W, Jia J, Shen Y-H, et al,. 2013. Functional expression of FIP-fve, a fungal immunomodulatory protein from the edible mushroom Flammulina velutipes in Pichia pastoris GS115. J Biotechnol 168: 527-533.
37. Martinez FO, Gordon S,. 2014. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 6, 1-13.
38. Morgan B,. 1996. Intervention in the complement system: a therapeutic strategy in inflammation. Biochem Soc Trans 24: 224-229.
39. Nash TH,. 2008. Lichen Biology. Cambridge University Press: Cambridge.
40. Neamati N, Hong H, Mazumder A, et al,. 1997. Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching. J Med Chem 40: 942-951.
41. Nishikawa Y, Takeda T, Shibata S, Fukuoka F,. 1969. Further investigation on the structures and the antitumor activity of the polysaccharides from Gyrophora esculenta Miyoshi and Lasailla papulosa (Ach.) Llano. Chem Pharm Bull 17: 1910-1916.
42. Noleto GR, Merce AL, Iacomini M, Gorin PA, Soccol VT, Oliveira MB,. 2002. Effects of a lichen galactomannan and its vanadyl (IV) complex on peritoneal macrophages and leishmanicidal activity. Mol Cell Biochem 233: 73-83.
43. Olafsdottir ES, Ingolfsdottir K,. 2001. Polysaccharides from lichens: structural characteristics and biological activity. Planta Med 67: 199-208.
44. Olafsdottir ES, Omarsdottir S, Paulsen BS, Jurcic K, Wagner H,. 1999a. Rhamnopyranosylgalactofuranan, a new immunologically active polysaccharide from Thamnolia subuliformis. Phytomedicine 6: 273-279.
45. Olafsdottir ES, Ingolfsdottir K, Barsett H, Smestad Paulsen B, Jurcic K, Wagner H,. 1999b. Immunologically active (1 → 3)-(1 → 4)-α-D-Glucan from Cetraria islandica. Phytomedicine 6: 33-39.
46. Olafsdottir ES, Omarsdottir S, Paulsen BS, Wagner H,. 2003. Immunologically active O6-branched (1 - >3)-beta-glucan from the lichen Thamnolia vermicularis var. subuliformis. Phytomedicine 10: 318-324.
47. Omarsdottir S, Freysdottir J, Barsett H, Paulsen BS, Olafsdottir ES,. 2005. Effects of lichen heteroglycans on proliferation and IL-10 secretion by rat spleen cells and IL-10 and TNF- secretion by rat peritoneal macrophages in vitro. Phytomedicine 12: 461-467.
48. Omarsdottir S, Freysdottir J, Olafsdottir ES,. 2007. Immunomodulating polysaccharides from the lichen Thamnolia vermicularis var. subuliformis. Phytomedicine 14: 179-184.
49. Ovodov Iu S,. 1998. Polysaccharides of flower plants: structure and physiological activity. Bioorg Khim 24: 483-501.
50. Patchen ML, Macvittie TJ,. 1983. Dose-dependent responses of murine pluripotent stem cells and myeloid and erythroid progenitor cells following administration of the immunomodulating agent glucan. Immunopharmacology 5: 303-313.
51. Ramberg JE, Nelson ED, Sinnott RA,. 2010. Immunomodulatory dietary polysaccharides: a systematic review of the literature. Nutr J 9: 1-22.
52. Schepetkin IA, Quinn MT,. 2006. Botanical polysaccharides: macrophage immunomodulation and therapeutic potential. Int Immunopharmacol 6: 317-333.
53. Schmeda-Hirschmann G, Tapia A, Lima B, et al,. 2008. A new antifungal and antiprotozoal depside from the Andean lichen Protousnea poeppigii. Phytother Res 22: 349-355.
54. Sharma P, Wagner K, Wolchok JD, Allison JP,. 2011. Novel cancer immunotherapy agents with survival benefit: recent successes and next steps. Nat Rev Cancer 11: 805-812.
55. Shivaprasad HN, Kharya MD, Rana AC, Mohan S,. 2006. Preliminary immunomodulatory activities of the aqueous extract of Terminalia chebula. Pharm Biol 44: 32-34.
56. Shrestha G, St. Clair LL,. 2013. Lichens: a promising source of antibiotic and anticancer drugs. Phytochem Rev 12: 229-244.
57. Silva D, Rapior S, Fons F, Bahkali A, Hyde K,. 2012. Medicinal mushrooms in supportive cancer therapies: an approach to anti-cancer effects and putative mechanisms of action. Fungal Divers 55: 1-35.
58. Stone BA, Clarke AE,. 1992. Chemistry and Biology of (1-3)-β-Glucans. La Trobe University Press: Victoria, Australia.
59. Stuelp P, Carneiro Leão A, Gorin P, Iacomini M,. 1999. The glucans of Ramalina celastri relation with chemotypes of other lichens. Carbohydr Polym 40: 101-106.
60. Stuelp-Campelo PM, de Oliveira MB, Leao AM, Carbonero ER, Gorin PA, Iacomini M,. 2002. Effect of a soluble α-D-glucan from the lichenized fungus Ramalina celastri on macrophage activity. Int Immunopharmacol 2: 691-698.
61. Subhashini P, Dilipan E, Thangaradjou T, Papenbrock J,. 2013. Bioactive natural products from marine angiosperms: abundance and functions. Nat Prod Bioprospect 3: 129-136.
62. Sun Y, Sun T, Wang F, et al,. 2013. A polysaccharide from the fungi of Huaier exhibits anti-tumor potential and immunomodulatory effects. Carbohydr Polym 92: 577-582.
63. Takeda T, Funatsu M, Shibata S, Fukuoka F,. 1972. Antitumor active polysaccharides of Evernia, Pacroscyphus and Alectoria species. Chem Pharm Bull 20: 2445-2449.
64. Tian J, Ma J, Ma K, et al,. 2013. β-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells. Eur J Immunol 43: 1220-1230.
65. Wagnerová J, Líšková A, Navarová J, Krištofová A, Trnovec T, Ferencík M,. 1993. The effect of two glucan carboxymethyl derivatives with various substitution degrees on cyclophosphamide immunosuppression in mice. Immunopharmacol Immunotoxicol 15: 227-242.
66. Wasser SP,. 2002. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 60, 258-274.
67. Wood S, Huffman J, Weber N, et al,. 1990. Antiviral activity of naturally occurring anthraquinones and anthraquinone derivatives. Planta Med 56: 651-652.
68. Yamamoto Y, Miura Y, Kinoshita Y, et al,. 1995. Screening of tissue cultures and thalli of lichens and some of their active constituents for inhibition of tumor promoter-induced Epstein-Barr virus activation. Chem Pharm Bull (Tokyo) 43: 1388-1390.
69. Yoon TJ, Koppula S, Lee KH,. 2013. The effects of β-glucans on cancer metastasis. Anticancer Agents Med Chem 13: 699-708.